This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Christine Engeland, MD, PhD
Physician-Scientist at NCT/DKFZ


Dr. Engeland received her medical degree from Heidelberg University. During her PhD at the German Cancer
Research Center (DKFZ) she developed oncolytic vectors encoding immune checkpoint antibodies. Since then,
her research has focused on targeted immunomodulation of the tumor microenvironment. The aim of her
work is to translate scientific results into clinical application to improve efficacy of cancer immunotherapy.